Abstract
Two trials of a telemedicine monitoring system were conducted in the UK. The SAFE21 system records the patient's physioloaical data which are transmitted via a modem to the health service provider. The first trial was conducted on nine muscular dystrophy patients under 1 years of age. Eight of the patients felt that the monitoring system was reliable and were happy with it as it avoided the need to go to hospital for monitoring. The second trial was carried out on 14 patients suffering from respiratory illness. Thirteen of these patients felt that the service was useful and 12 reported satisfaction with the system. The SAFE21 telemedicine monitoring system appears to be an acceptable means of delivering care.
Get full access to this article
View all access options for this article.